Clinical trial Recruiting at 3 sites Interventional Ages 40 to 90 Men only

Comparing two laser techniques for prostate surgery

Official title: Prospective and Randomized Analysis of Endoscopic Prostate Enucleation Using Moses 2.0 Technology Versus the New Thulium Fiber Laser in Medium and Large Prostates.

Run by Fundacio Puigvert · NCT06565741 · Data updated 2026-11-12

This study is testing which of two laser surgery techniques works better for men with medium to large prostates who need help with urinary problems.

Quick facts

Study typeInterventional
Ages40 Years to 90 Years
SexMen only
Enrollment120 (estimated)
SponsorFundacio Puigvert
Academic / other
Locations3 sites (Barcelona, BARCELONA and 2 other locations)
StatusRecruiting
StartedSeptember 3, 2024
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedApril 29, 2026
Trial IDNCT06565741 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are males aged 40 to 90 years with medium to large prostates and significant lower urinary tract symptoms.

Probably not a fit

Patients with a history of urethral stenosis or previous prostate surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of two laser techniques, MoLEP and ThuFLEP, for endoscopic anatomical enucleation of the prostate in men with medium to large prostates. The study will evaluate the enucleation efficiency and perioperative bleeding associated with each technique. A total of 120 male patients aged 40 to 90 years, who are candidates for surgery due to lower urinary tract symptoms, will be randomly assigned to one of the two treatment groups. Follow-up assessments will occur at various intervals post-surgery to monitor outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced recovery times for patients undergoing prostate surgery.

How similar studies have gone: Previous studies have shown promising results with both laser techniques, but this specific comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males aged between 40 and 90 years.
* Patients who, due to their lower urinary tract symptoms, are candidates for

BPH surgery, including:

* Obstructive urinary symptoms evaluated through IPSS with a score \>7 and QoL \> 2 or acute urinary reten on refractory to catheter removal.
* Obstructive urinary flow evaluated through uroflowmetry with Qmax\< 15 ml/s, obstruction demonstrated by pressure/flow study, prostatic origin haematuria refractory to medical treatment, or acute urinary retention refractory to catheter removal.

  * Prostatic volume measured by transabdominal ultrasound, transrectal ultrasound, or magnetic resonance imaging of more than 80 cc.
  * Prostate-specific antigen (PSA) \< 4 ng/ml, or with multiparametric prostate magnetic resonance imaging reporting PIRADS \< 3 or equal to 3 with PSA density \< 15%.

Exclusion Criteria:

* Diagnosis, suspicion, or history of urethral stenosis or urethral surgery.
* History of prostate surgery or pelvic radiotherapy.
* Diagnosis or suspicion of prostate cancer or urothelial cancer.
* Body mass index superior to 30.

Where it's running

  • Fundacio Puigvert
    Barcelona, Barcelona, Spain
    Recruiting
  • Clinic Hospital of Barcelona
    Barcelona, Barcelona, Spain
    Recruiting
  • Hospital Univesitari de Bellvitge
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.